WOGONIN

  1. … (notably the C-glycosides carlinoside, isoorientin, isoscoparin, neocarlinoside, schaftoside and neoschafto-side); oestrogenic (Wogonin); and oviposition stimulants …
  2. … and Biopharmaceutics Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and Wogonin to breast cancer
  3. … LC-MS/MS assay for the determination of Wogonin: Application to a preclinical pharmacokinetics and bioavailability of different Wogonin administration in beagle dogs
  4. … of inflammation‐associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by Wogonin
  5. < Originals> Inhibitory effects of baicalein and Wogonin on the growth of B16 melanoma cells
  6. 290. The constitution of oroxylin-A. Part II. Attempted synthesis of oroxylin-A and the synthesis of Wogonin
  7. A flavone, Wogonin from Scutellaria baicalensis inhibits the proliferation of human colorectal cancer cells by inducing of autophagy, apoptosis and G2/M cell …
  8. A novel process related impurity and forced degradation study of synthetic Wogonin: Development of a liquid chromatographic method for purity control
  9. A novel prostate-specific membrane-antigen (PSMA) targeted micelle-encapsulating Wogonin inhibits prostate cancer cell proliferation via inducing intrinsic apoptotic …
  10. A nti-Hepatic Cirrhosis E ffects of Schizandrin, Glycyrrhizinic acid and Wogonin on TAA-induced Hepatic Cirrhosis in Primary Cultured Rat Hepatocyte and …
  11. A Practical and Efficient Approach to the Preparation of Bioactive Natural Product Wogonin
  12. A Wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects
  13. A Wogonin-rich-fraction of Scutellaria baicalensis root extract exerts chondroprotective effects by suppressing IL-1β-induced activation of AP-1 in human OA …
  14. Abstract C99: Wogonin enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by Nrf2 suppression in …
  15. Activities of Wogonin Analogs and Other Flavones against Flavobacterium columnare
  16. Acute lung injury induced by lipopolysaccharide is inhibited by Wogonin in mice via reduction of Akt phosphorylation and RhoA activation
  17. Acute Toxicity Test of Wogonin in Mice
  18. Advance in studies on antitumor and immunomodulatory effects of Wogonin
  19. Advances of Wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors
  20. Aislamiento selectivo y de alto rendimiento de Wogonin puro a partir de partes aéreas de Scutellaria havanensis Jacq.
  21. An enhanced preparation and purification of the major antioxidants baicalein and Wogonin from Scutellariae radix
  22. An overview and comparison of a recombinant antigen-binding fragment and an antigen-binding fragment from a monoclonal antibody against Wogonin glucuronide
  23. Analysis and comparison of baicalin, baicalein and Wogonin contents in traditional decoctions and commercial extracts of Scutellariae radix
  24. Analysis of baicalein, baicalin and Wogonin in Scutellariae radix and its preparation by microemulsion electrokinetic chromatography with 1-butyl-3-methylimizolium …
  25. Anti-cancer scopes and associated mechanisms of Scutellaria extract and flavonoid Wogonin
  26. Anti-fibrotic effect of Wogonin in renal tubular epithelial cells via Smad3-dependent mechanisms
  27. Anti-hepatitis B virus activity of Wogonin in vitro and in vivo
  28. Anti-hepatitis B virus effects of Wogonin isolated from Scutellaria baicalensis
  29. Anti-inflammatory effect of Wogonin on allergic responses in ovalbumin-induced allergic rhinitis in the mouse
  30. Anti-inflammatory effect of Wogonin on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid
  31. Anti-inflammatory Effects of Baicalin, Baicalein, and Wogonin In Vitro and In Vivo
  32. Anti-Proliferative Effect of Wogonin on Ovary Cancer Cells Involves Activation of Apoptosis and Cell Cycle Arrest
  33. Anti-tumor activity of Wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways
  34. Anti-tumor and anti-metastatic actions of Wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis
  35. Anticancer effect of nor-Wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3
  36. Anticancer effects of Wogonin in both estrogen receptor‐positive and ‐negative human breast cancer cell lines in vitro and in nude mice xenografts
  37. Anticoagulant effect of Wogonin against tissue factor expression
  38. Anticonvulsant effect of Wogonin isolated from Scutellaria baicalensis
  39. Antifungal activity of Wogonin
  40. Antioxidant and free radical scavenging effects of baicalein, baicalin and Wogonin.
  41. Antithrombotic activities of Wogonin and wogonoside via inhibiting platelet aggregation
  42. Antitumor actions of baicalein and Wogonin in HT-29 human colorectal cancer cells
  43. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and Wogonin on bladder cancer cell lines
  44. Anxiolytic effect of Wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi
  45. Apigenin and Wogonin regulate epidermal growth factor receptor signaling pathway involved in MUC5AC mucin gene expression and production from …
  46. Apoptosis induction and imaging of cadmium-telluride quantum dots with Wogonin in multidrug-resistant leukemia K562/A02 cell
  47. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic ferroferric oxide nanoparticles loaded with Wogonin
  48. Application of Wogonin for preparing medicine to treat or prevent hepatitis B
  49. Application of Wogonin in the preparing of medicine for treating gastric cancer
  50. Baicalein and Wogonin are activators of rat TREK‐2 two‐pore domain K+ channel
  51. Baicalein and Wogonin inhibit collagen deposition in SHR and WKY cardiac fibroblast cultures
  52. Baicalein, Wogonin, and Scutellaria baicalensis ethanol extract alleviate ovalbumin-induced allergic airway inflammation and mast cell-mediated anaphylactic …
  53. Baicalin, baicalein and Wogonin inhibits high glucose-induced vascular inflammation in vitro and in vivo
  54. Binding of Wogonin to human gammaglobulin
  55. Binding of Wogonin to human serum albumin: a common binding site of Wogonin in subdomain IIA
  56. BisGMA‐induced cytotoxicity and genotoxicity in macrophages are attenuated by Wogonin via reduction of intrinsic caspase pathway activation
  57. BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin
  58. C36 NOVEL MECHANISMS OF ALLERGIC AIRWAY INFLAMMATION IN ANIMAL MODELS: Wogonin Attenuates Allergic Neutrophilic Airway Inflammation By …
  59. Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?
  60. Cardio protective role of Wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation
  61. Catalase suppression‐mediated H2O2 accumulation in cancer cells by Wogonin effectively blocks tumor necrosis factor‐induced NF‐κB activation and sensitizes …
  62. Changes in mitochondrial membrane potential and reactive oxygen species during Wogonin‐induced cell death in human hepatoma cells
  63. Characterization and bioavailability of Wogonin by different administration routes in beagles
  64. Chinese herbal remedy Wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells
  65. Chondroprotective effects of Wogonin in experimental models of osteoarthritis in vitro and in vivo
  66. Combination of icotinib and Wogonin induces apoptosis and autophagy to overcome acquired resistance in lung cancer harbouring EGFR T790M mutation
  67. Combination of Wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition
  68. Combined activity of oridonin and Wogonin in advanced-stage ovarian cancer cells
  69. Comparative pharmacokinetic and tissue distribution study of baicalin, baicalein, wogonoside, Wogonin and oroxylin-A after oral administration of Component …
  70. Comparative pharmacokinetics of baicalin, wogonoside, baicalein and Wogonin in plasma after oral administration of pure baicalin, radix scutellariae and …
  71. Convenient synthesis of Wogonin, a flavonoid natural product with extensive pharmacological activity
  72. Correction: Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-κB Signaling after Experimental Traumatic Brain Injury
  73. Corrigendum to” Inhibitory effects of Wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix …
  74. Corrigendum to” Selective anti-tumor activity of Wogonin targeting the Warburg effect through stablizing p53″[Pharmacol. Res. 135 (2018) 49-59].
  75. Corrigendum to” Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1″[Toxicology 305 (2013) 10-19].
  76. Corrigendum to” Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein”[Toxicology and Applied Pharmacology 271 (2013) 144-145].
  77. Cryptotanshinone and Wogonin up-regulate eNOS in vascular endothelial cells via ERα and down-regulate iNOS in LPS stimulated vascular smooth muscle cells via …
  78. Cytotoxicity and radiosensitizing effect of Wogonin, an extract from Scutellaria litwinowii, in head and neck squamous cell carcinoma line HN5.
  79. Dataset of effect of Wogonin, a natural flavonoid, on the viability and activation of NF-κB and MAPKs in IL-1β-stimulated human OA chondrocytes
  80. Design of Wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity
  81. Determination of baicalin and Wogonin in Chantui Zhike Granules by HPLC
  82. Determination of Baicalin and Wogonin in Tongjing Patch by HPLC
  83. Determination of Baicalin and Wogonin in XiaoErReSuQing Granules by HPLC [J]
  84. Determination of Baicalin, Baicalein and Wogonin in Ten Wild Scutellaria baicalensis from Shanxi
  85. Determination of Berberine Hydrochloride, Baicalin and Wogonin in Yankening Pian by HPLC
  86. Determination of gentiopicroside, mangiferin, palmatine, berberine, baicalin, Wogonin and glycyrrhizin in the traditional Chinese medicinal preparation Sann …
  87. Determination of GL‐V9, a derivative of Wogonin, in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study after oral and pulmonary …
  88. Determination of pK a values of wogonoside, Wogonin and oroxylin-A by RP-HPLC
  89. Determination of Wogonin in rat plasma by liquid chromatography and its pharmacokinetic application
  90. Determination of Wogonin in rat plasma by liquid chromatography-tandem mass spectrometry
  91. Determination on the Content of Wogonin in Qinzhu Tongjing Patch by HPLC
  92. Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, Wogonin, oroxylin A and their glucuronides baicalin, wogonoside and …
  93. Development of an immunoassay using an anti-Wogonin glucuronide monoclonal antibody
  94. Development of new HPLC method for Wogonin in rat plasma: Compatibility of standard and test samples
  95. Developmental toxicity and genotoxicity studies of Wogonin
  96. Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid Wogonin among human cancer cells and normal diploid cell
  97. Different apoptotic effects of Wogonin via induction of H2O2 generation and Ca2+ overload in malignant hepatoma and normal hepatic cells
  98. Different effects of baicalein, baicalin and Wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines
  99. Differential apoptotic effect of Wogonin and nor‐Wogonin via stimulation of ROS production in human leukemia cells
  100. Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro
  101. Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity
  102. Drug resistance associates with activation of Nrf2 in MCF‐7/DOX cells, and Wogonin reverses it by down‐regulating Nrf2‐mediated cellular defense response
  103. Dual Effect of Wogonin on TREK-2 Expression and Channel Activity
  104. Effect and mechanism of Wogonin on NF-κB nuclear translocation and expression in NR8383 cells infected by influenza virus [J]
  105. Effect of magnetic nanoparticles of Fe3O4 and Wogonin on the reversal of multidrug resistance in K562/A02 cell line
  106. Effect of magnetic nanoparticles on apoptosis and cell cycle induced by Wogonin in Raji cells
  107. Effect of Wogonin on OSCC cell growth and invasion
  108. Effect of Wogonin on OSCC cell growth and invasion
  109. Effect of Wogonin on osteosarcoma cells and its mechanism based on a PI3K/Akt signaling pathway
  110. Effect of Wogonin on spatial memory and its possible mechanisms in chronic cerebral ischemia in rats
  111. Effect of Wogonin on the Proliferation in Acute Myeloid Leukemia HL-60 Cell Through Inhibition of PI3K/Akt/mTOR Signaling Pathway
  112. Effect of Wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in …
  113. Effects of baicalein and Wogonin isolated from Scutellaria baicalensis roots on skin damage in acute UVB-irradiated hairless mice
  114. Effects of baicalein and Wogonin on drug-metabolizing enzymes in C57BL/6J mice
  115. Effects of baicalin and Wogonin on mucin release from cultured airway epithelial cells
  116. Effects of baicalin, baicalein, and Wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-κb binding activities induced by interleukin-1β in human …
  117. Effects of scutellariae radix extract and its components (baicalein, baicalin, and Wogonin) on the experimental elevation of aqueous flare in pigmented rabbits
  118. Effects of the Wogonin on LPS induced iNOS expression in BV2 cells
  119. Effects of Wogonin on Apoptosis, Invasion, Migration and Wnt/β-Catenin Signaling Pathway of Gastric Cancer Cells SGC7901
  120. Effects of Wogonin on inducing apoptosis of human ovarian cancer A2780 cells and telomerase activity
  121. Effects of Wogonin on inflammation-related factors in alveolar macrophages infected with influenza virus [J]
  122. Effects of Wogonin on LPS-induced IL-6 and RANTES production [J]
  123. Effects of Wogonin on LPS-induced NO and MCP-1 production
  124. Effects of Wogonin on LPS-induced production of proinflammatory cytokines [J]
  125. Effects of Wogonin on Proliferation and Cell Cycle of SPC-A-1 Cells
  126. Effects of Wogonin on the Apoptosis of Human Glioma Cell Line U251 [J]
  127. Effects of Wogonin on the levels of cytokines and functions of leukocytes associated with NF-kappa B expression in Sprague-Dawley rats
  128. Effects of Wogonin on the mechanism of melanin synthesis in A375 cells
  129. Effects of Wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression
  130. Effects of Wogonin, wogonoside, and 3, 5, 7, 2′, 6′-pentahydroxyflavone on chemical mediator production in peritoneal exduate cells and immunoglobulin E of rat …
  131. Efficacy of Wogonin in the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium
  132. Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by Wogonin via the PI3K/Akt pathway
  133. Enhancement of solubility and dissolution rate of baicalein, Wogonin and oroxylin A extracted from Radix scutellariae
  134. Enzymatic extraction of baicalein and Wogonin from radix scutellariae
  135. Experimental study on inhibitory effect of Wogonin on proliferation and invasion of breast cancer cells
  136. Flavonoid Wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia
  137. Functional role of Wogonin in anti-angiogenesis
  138. Genetic and Environmental Variations in Baicalin, Baicalein and Wogonin Contents in Scutellaria baicalensis
  139. GSK3β/β-catenin signaling is correlated with the differentiation of glioma cells induced by Wogonin
  140. High-yield production of scutellaria radix flavonoids (baicalein, baicalin and Wogonin) by liquid-culture of Scutellaria baicalensis root-derived cells
  141. High‐dose Wogonin exacerbates DSS‐induced colitis by up‐regulating effector T cell function and inhibiting Treg cell
  142. Histopathological Comparison of Animal Models of Skin Inflammation and Inhibition of the Inflammatory Responses by Plant Flavonoid, Wogonin
  143. Identification and quantification of baicalein, Wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix …
  144. In vitro and in vivo inhibitory activities of rutin, Wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production
  145. In Vitro Inhibitory Effect of Wogonin on Human Osteosarcoma
  146. In Vivo Hepatoprotective Effect of Baicalein, Baicalin and Wogonin from Scutellaria rivularis
  147. In vivo pharmacokinetics and tissue distribution of Wogonin albumin microspheres in rats [J]
  148. Influence of Adriamycin and Wogonin on the Expression of Mir-155 in Burrkit Lymphoma in Vitro
  149. Inhibition of breast cancer metastases to bone by baicalein, baicalin and Wogonin derived from Scutellaria radix
  150. Inhibition of contact dermatitis in animal models and suppression of proinflammatory gene expression by topically applied flavonoid, Wogonin
  151. Inhibition of Lithium Sensitive Orai1/STIM1 Expression and Store Operated Ca2+ Entry in Chorea-Acanthocytosis Neurons by NF-κB Inhibitor Wogonin
  152. Inhibition of Lung Cancer Proliferation by Wogonin is Associated with Activation of Apoptosis and Generation of Reactive Oxygen Species
  153. Inhibition of prostaglandin E2 production by synthetic Wogonin analogs
  154. Inhibition of TNF‐α‐induced MUC5AC mucin gene expression and production by Wogonin through the inactivation of NF‐κB signaling in airway epithelial cells
  155. Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by Wogonin, a plant flavone from Scutellaria radix
  156. Inhibitory effect of baicalin, baicalein and Wogonin on secretory group IIA phospholipase A2
  157. Inhibitory effect of Wogonin on gastric cancer SGC7901 cell line in vitro
  158. Inhibitory effect of Wogonin on the mouse ascites hepatocarcinoma and its mechanism
  159. Inhibitory effect of Wogonin on the proliferation and invasion of glioblastoma U87 cells and related mechanism
  160. Inhibitory effects of baicalein and Wogonin on lipopolysaccharide‐induced nitric oxide production in macrophages
  161. Inhibitory effects of Wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes
  162. Inhibitory effects of Wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen …
  163. Inhibitory effects of Wogonin on lung cancer A549 cell line in vitro.
  164. Inhibitory effects of Wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9
  165. Interaction of Wogonin with bovine serum albumin
  166. Intervention impact of Wogonin on type 1 diabetic mice and its influence on p62dok expression in liver
  167. Involvement of bax/bcl-2 in Wogonin-induced apoptosis of human hepatoma cell line SMMC-7721
  168. Isolation and purification of baicalein, Wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography
  169. Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein, baicalin, oroxylin A and Wogonin in rat plasma
  170. Main signal pathways underlying the molecular mechanisms of the antitumor effects of Wogonin
  171. Mechanism in the existent difference in form of Wogonin/wogonoside between plasma and intestine/liver in rats
  172. Mechanism of Wogonin-mediated sensitization of HTLV-1-associated ATL cells to TRAIL-induced apoptosis
  173. Mechanism research of proliferation and killing hepatoma cell of CD3AK cell by Wogonin
  174. Mechanistic study of absorption and first‐pass metabolism of GL‐V9, a derivative of Wogonin
  175. Mediating macrophage immunity with Wogonin in mice with vascular inflammation
  176. Molecular characterization of flavonoid biosynthetic genes and accumulation of baicalin, baicalein, and Wogonin in plant and hairy root of Scutellaria …
  177. Molecular Mechanism of Wogonin Inhibiting Hepatocellular Cancer Cells Growth by Gene Chip
  178. Nephroprotective effect of Wogonin against cadmium-induced nephrotoxicity via inhibition of oxidative stress–induced MAPK and NF-kB pathway in Sprague Dawley …
  179. Neuroprotective effect of Wogonin in a rodent model of permanent focal cerebral ischemia
  180. Neuroprotective effect of Wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation
  181. Neuroprotective effect of Wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation
  182. Neuroprotective effect of Wogonin on Rat’s brain exposed to gamma irradiation
  183. Neuroprotective effect of Wogonin: potential roles of inflammatory cytokines
  184. Neuroprotective effects of baicalein, baicalin, and Wogonin in primary cuItured rat cortical cells
  185. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
  186. NF-κ B and Nrf2 signaling pathways contribute to Wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis
  187. Novel platinum (IV) complexes conjugated with a Wogonin derivative as multi-targeted anticancer agents
  188. O-methylated Flavone Wogonin Specifically Reduces Melanosome Transport through Downregulation of Melanophilin
  189. P23. Inhibitory effects of baicalein, baicalin and Wogonin on osteolytic bone metastasis of breast cancer
  190. Pharmacokinetic properties of Wogonin and its herb–drug interactions with docetaxel in rats with mammary tumors
  191. Pharmacokinetics of baicalein, baicalin and Wogonin after oral administration of a standardized extract ofScutellaria baicalensis, PF-2405 in rats
  192. Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of Wogonin in rats
  193. Phorbol ester or epidermal growth‐factor‐induced MUC5AC mucin gene expression and production from airway epithelial cells are inhibited by apigenin and Wogonin
  194. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by Wogonin from Scutellaria baicalensis Georgi
  195. Potential therapeutic effects of baicalein, baicalin, and Wogonin in ocular disorders
  196. Preliminary Research on the Inducing Effects of Wogonin on the Apoptosis of Lung Cancer Cells and Its Mechanism
  197. Preparation and in vitro Drug Release of Wogonin-loaded Solid Lipid Nanoparticles
  198. Preparation and its in vitro release of Wogonin albumin microspheres [J]
  199. Preparation of Wogonin from Radix Scutellariae and its Inhibitory Effects on the Growth of HepG2 Cells
  200. Prevention of Wogonin on colorectal cancer tumorigenesis by regulating p53 nuclear translocation
  201. Preventive effect of the flavonoid, Wogonin, against ethanol-induced gastric mucosal damage in rats
  202. Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by Wogonin
  203. Progress on inclusion complexes of baicalein and Wogonin with cyclodextrins
  204. Protection Effect of Wogonin on Mice with Hyperlipidemia
  205. Protective effect of Wogonin on endotoxin‐induced acute lung injury via reduction of p38 MAPK and JNK phosphorylation
  206. Protective Effect of Wogonin on Endotoxin‐Induced Lethal Shock in D‐Galactosamine‐Sensitized Mice
  207. Protective effect of Wogonin on proinflammatory cytokine generation via Jak1/3-STAT1/3 pathway in lipopolysaccharide stimulated BV2 microglial cells
  208. Protective effects of baicalein and Wogonin against benzo [a] pyrene-and aflatoxin B1-induced genotoxicities
  209. Protective effects of baicalein and Wogonin against mutagen-induced genotoxicities
  210. Protective effects of Wogonin against Alzheimer’s disease by inhibition of amyloidogenic pathway
  211. Protective role of Wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1
  212. Quantitation of the flavonoid Wogonin and its major metabolite Wogonin-7β-d-glucuronide in rat plasma by liquid chromatography–tandem mass spectrometry
  213. Reactive oxygen species up‐regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and Wogonin
  214. Recombinant soluble CD40 ligand enhances Wogonin-induced antitumor activity
  215. Relaxant effect induced by Wogonin from Scutellaria baicalensis on rat isolated uterine smooth muscle
  216. Research of Wogonin enchancing the sensitivity of A549 cells to TRAIL-induced apoptosis
  217. Response of human non-small-cell lung cancer cells to the influence of Wogonin with SGK1 dynamics
  218. Reversal of cisplatin resistance in human gastric cancer cells by a Wogonin-conjugated Pt (IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB …
  219. Role of p53, PUMA, and Bax in Wogonin-induced apoptosis in human cancer cells
  220. Scutellaria extract and Wogonin inhibit tumor-mediated induction of Treg cells via inhibition of TGF-β1 activity
  221. Selective and high yield isolation of pure Wogonin from aerial parts of Scutellaria havanensis Jacq
  222. Selective anti-tumor activity of Wogonin targeting the Warburg effect through stablizing p53
  223. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and Wogonin to breast cancer
  224. Simulatneous determination of baicalein, Wogonin, oroxylin-A and their glucuronides in scutellariae radix by ion-pair high-performance liquid chromatography
  225. Simultaneous determination of aloe-emodin, rhein, emodin, physcion, chrysophanol, baicalin, Wogonin, berberine hydrochloride in Yiqing granules by HPLC [J]
  226. Simultaneous determination of baicalein and Wogonin in Chinese medicinal plant Scutellaria baicalensis using HPLC–DAD coupled with alternating trilinear …
  227. Simultaneous determination of baicalein, baicalin, Wogonin, and wogonoside in rat plasma by LC-MS/MS for studying the pharmacokinetics of the standardized extract …
  228. Simultaneous determination of baicalein, chrysin and Wogonin in four Iranian Scutellaria species by high performance liquid chromatography
  229. Simultaneous Determination of Baicalein, Wogonin and its Glycosides in Scutellariae Radix Extract by HPLC in Isocratic Mode.
  230. Simultaneous determination of baicalin, baicalein and Wogonin in Qinlian tablets by HPLC [J]
  231. Simultaneous Determination of Baicalin, Baicalein and Wogonin In Radix Scutellariae by HPLC [J]
  232. Simultaneous determination of baicalin, baicalein and Wogonin in Xiaoyan tablets by HPLC
  233. Simultaneous determination of baicalin, baicalein, Wogonin, berberine, palmatine and jatrorrhizine in rat plasma by liquid chromatography–tandem mass spectrometry …
  234. Simultaneous determination of baicalin, baicalein, Wogonin, oxysophocarpine, oxymatrine and matrine in the chinese herbal preparation of sanwu-huangqin-tang by …
  235. Simultaneous determination of baicalin, baicalein, wogonoside, Wogonin, scutellarin, berberine, coptisine, ginsenoside Rb1 and ginsenoside Re of Banxia xiexin …
  236. Simultaneous determination of baicalin, wogonoside, baicalein, Wogonin, berberine, coptisine, palmatine, jateorrhizine and glycyrrhizin in Kampo medicines by ion …
  237. Simultaneous determination of baicalin, wogonoside, baicalein, Wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography …
  238. Simultaneous Determination of Chlorogenic Acid, Forsythin, Baicalin and Wogonin in Shuanghuanglian Oral Liquid by Wavelength Conversion HPLC [J]
  239. Simultaneous determination of sodium salvianic A baicalin, baicalein, Wogonin, wogonoside and tanshinone A in chidan pills by HPLC
  240. Simultaneous Determination of Sodium Salvianic A Baicalin, Baicalein, Wogonin, Wogonoside and TanshinoneⅡA in Chidan Pills by HPLC
  241. Simultaneous determination of Wogonin, oroxylin a, schisandrin, paeoniflorin and emodin in rat serum by HPLC–MS/MS and application to pharmacokinetic studies
  242. Simultaneous Determination of Wogonin, Scutellarin, Baicalin, and Baicalein in Extracts from Scutellariae Baicalensis by High-Performance Liquid Chromatography …
  243. Simultaneous LC–MS Analysis and of Wogonin and oroxylin a in rat plasma, and pharmacokinetic studies after administration of the active fraction from Xiao-Xu-Ming …
  244. Skullcap (Scutellaria baicalensis) extract and its active compound, Wogonin, inhibit ovalbumin-induced Th2-mediated response
  245. SPE and LC for analysis of the tissue distribution of Wogonin and its metabolite in tumor-bearing nude mice
  246. Strong inhibition capability of Wogonin towards UDP-glucuronosyltransferase (UGT) 1A1 and 1A3
  247. Structure and antiinflammatory activity relationships of Wogonin derivatives
  248. Structure-activity relationship study between baicalein and Wogonin by spectrometry, molecular docking and microcalorimetry
  249. Study of the inclusion complex and antioxidating activity of Wogonin with β-cyclodextrin and hydroxypropyl-cyclodextrin
  250. Study on extraction and isolation of Wogonin from the root of Scutellaria [J]
  251. Study on Pharmacokinetics and Distribution of Wogonin Solid Lipid Nanoparticles in Rats
  252. Study on plasma concentration and bioavailability of Wogonin in Beagle’s dogs
  253. Study on Plasma Concentration and Bioavailability of Wogonin in Beagle’s Dogs
  254. Study on the Effect of Wogonin on Telomerase Gene of Nude Mice with Transplanted Human Ovarian Cancer SKOV3 Cells and its Relationship with Apoptosis [J]
  255. Studying on inclusion complexes of Wogonin with β-cyclodextrin and hydroxypropyl-cyclodextrin
  256. Subchronic toxicity and plasma pharmacokinetic studies on Wogonin, a natural flavonoid, in Beagle dogs
  257. Suppression of cyclooxygenase-2 expression of skin fibroblasts by Wogonin, a plant flavone from Scutellaria radix
  258. Sustained cytotoxicity of Wogonin on breast cancer cells by encapsulation in solid lipid nanoparticles
  259. Sustained Effect of Wogonin-loaded Solid Lipid Nanoparticles on Apoptosis in MCF-7 Cells
  260. Synergistic effect of baicalein, Wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of …
  261. Synergistic effect of baicalein, Wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of …
  262. Synergistic inhibitory effect of Wogonin and low-dose paclitaxel on gastric cancer cells and tumor xenografts
  263. Synthesis of Wogonin Analogs and Their Biological Effects
  264. Synthesis, characterization and bacteriastatic activities of Wogonin and its Cu (Ⅱ), Co (Ⅱ), Ni (Ⅱ) complexes [J]
  265. Synthesis, characterize and antioxidating activity of the inclusion complex of Wogonin with β-cyclodextrin and hydroxypropyl-cyclodextrin
  266. Synthesis, evaluation and quantitative structure–activity relationship (QSAR) analysis of Wogonin derivatives as cytotoxic agents
  267. Synthesis, Investigation on Immunity and Cancer Prevention of Wogonin Derivatives
  268. Synthetic Wogonin derivatives suppress lipopolysaccharide-induced nitric oxide production and hydrogen peroxide-induced cytotoxicity
  269. Targeting CDK9 by Wogonin and related natural flavones potentiates the anti‐cancer efficacy of the Bcl‐2 family inhibitor ABT‐263
  270. Targeting Nrf2 with Wogonin overcomes cisplatin resistance in head and neck cancer
  271. The Anti-inflammatory Activity of Scutellaria rivularis Extracts and Its Active Components, Baicalin, Baicalein and Wogonin
  272. The anticancer activities of Wogonin in murine sarcoma S180 both in vitro and in vivo
  273. The Antitumor effect of Wogonin, a lipoxygenase inhibitor, in both estrogen receptor-positive and-negative human breast cancers.
  274. The effect of varying the peptide linker length in a single chain variable fragment antibody against Wogonin glucuronide
  275. The Establishment of the Quantitative Model of Wogonin in Radix Scutellariae
  276. The Flavonoid Wogonin Reduces CLL Cell Survival in Vitro and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling
  277. The inhibitory role of Wogonin on tumor growth and telomerase activity of human ovarian cancer SKOV3 cell line xenograf in nude mice
  278. The inhibitory role of Wogonin on tumor growth and telomerase activity of human ovarian cancer SKOV3 cell line xenograf in nude mice
  279. The mitochondrial pathway in baicalein and Wogonin-induced apoptosis in human colorectal cancer cells
  280. The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and Wogonin
  281. The plant flavonoid Wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production
  282. The Quantitative Study on Baicalin and Wogonin of Radix Scutellariae by Self Enz ymatic Hydrolysis [J]
  283. The reference genome sequence of Scutellaria baicalensis provides insights into the evolution of Wogonin biosynthesis
  284. The role of Wogonin in controlling SOCS3 expression in neuronal cells
  285. Themes: Title: Study of Wogonin & radiotherapy-induced cytotoxicity and apoptosis in HN5cell line
  286. Therapeutic potential of Wogonin: a naturally occurring flavonoid
  287. Therapy effects of Wogonin on ovarian cancer cells
  288. TNF receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid Wogonin
  289. Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis
  290. Toxicological studies of Wogonin in experimental animals
  291. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid Wogonin
  292. Tumor necrosis factor-producing activity of Wogonin in RAW 264.7 murine macrophage cell line
  293. Urinary pharmacokinetics of baicalein, Wogonin and their glycosides after oral administration of Scutellariae Radix in humans
  294. Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of Wogonin and oroxylin A by human liver and intestinal …
  295. Vascular barrier protective effects of baicalin, baicalein and Wogonin in vitro and in vivo
  296. Vascular relaxation induced by Eucommiae Ulmoides Oliv. and its compounds Oroxylin A and Wogonin: implications on their cytoprotection action
  297. Vasodilatory effect of Wogonin on the rat aorta and its mechanism study
  298. Wogonin a Promising Component of Scutellaria baicalensis: A Review on its Chemistry, Pharmacokinetics and Biological Activities
  299. Wogonin Affecting Proliferation Activity of Human Lung Cancer A549 Cell in Vitro
  300. Wogonin affects proliferation and the energy metabolism of SGC‑7901 and A549 cells
  301. Wogonin Alleviates Hyperglycemia Through Increased Glucose Entry into Cells Via AKT/GLUT4 Pathway
  302. Wogonin ameliorate complete Freund’s adjuvant induced rheumatoid arthritis via targeting NF‐κB/MAPK signaling pathway
  303. Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice
  304. Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway
  305. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and …
  306. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK …
  307. Wogonin and Its Analogs
  308. Wogonin and neobaicalein from Scutellaria litwinowii roots are apoptotic for HeLa cells
  309. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1
  310. Wogonin and related natural flavones overcome TRAIL-resistance of tumors by down-regulation of c-FLIP and Up-regulation of TRAIL-R2 expression
  311. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c …
  312. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU. 1 pathway
  313. Wogonin Attenuates Allergic Neutrophilic Airway Inflammation By Inducing Neutrophil Apoptosis
  314. Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties
  315. Wogonin attenuates endotoxin‐induced prostaglandin E2 and nitric oxide production via Src‐ERK1/2‐NFκB pathway in BV‐2 microglial cells
  316. Wogonin attenuates etoposide-induced oxidative DNA damage and apoptosis via suppression of oxidative DNA stress and modulation of OGG1 expression
  317. Wogonin attenuates high glucose-induced human breast cancer cell MCF-7 viability, migration and invasion via the expression of AKT, PKCδ and p38 MAPK
  318. Wogonin attenuates hippocampal neuronal loss and cognitive dysfunction in Trimethyltin-intoxicated rats
  319. Wogonin attenuates inflammation by activating PPAR-γ in alcoholic liver disease
  320. Wogonin attenuates isoprenaline-induced myocardial hypertrophy in mice by suppressing the PI3K/akt pathway
  321. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis
  322. Wogonin attenuates nasal polyp formation by inducing eosinophil apoptosis through HIF-1α and survivin suppression
  323. Wogonin attenuates ovalbumin antigen-induced neutrophilic airway inflammation by inhibiting th17 differentiation
  324. Wogonin attenuates the deleterious effects of traumatic brain injury in anesthetized Wistar rats
  325. Wogonin but not Nor-Wogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages
  326. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP …
  327. Wogonin enhances intracellular adiponectin levels and suppresses adiponectin secretion in 3T3-L1 adipocytes
  328. Wogonin enhances tumor necrosis factor-related apoptosis-inducing ligand’s antitumor activity in vivo through H2O2-mediated downregulation of X-linked inhibitor of …
  329. Wogonin exacerbates the cytotoxic effect of oxaliplatin by inducing nitrosative stress and autophagy in human gastric cancer cells
  330. Wogonin exerts anti-inflammatory effect by disrupting keap-1/Nrf2 interactions and activating Nrf2 in human OA chondrocytes
  331. Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung …
  332. Wogonin hosted@ β-cyclodextrin: structural, electronic and nuclear studies
  333. Wogonin improves functional neuroprotection for acute cerebral ischemia in rats by promoting angiogenesis via TGF-β1
  334. Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-κB signaling after experimental traumatic brain injury
  335. Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway
  336. Wogonin increases doxorubicin sensitivity by down-regulation of IGF-1R/AKT signaling pathway in human breast cancer.
  337. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer’s disease
  338. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63
  339. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner
  340. Wogonin induced cytotoxicity in human hepatocellular carcinoma cells by activation of unfolded protein response and inactivation of AKT
  341. Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCδ phosphorylation
  342. Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells
  343. Wogonin induced mitochondrial dysfunction and endoplasmic reticulum stress in human malignant neuroblastoma cells via IRE1α-dependent pathway
  344. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K–AKT pathway
  345. Wogonin induces apoptosis and endoplasmic reticulum stress in HL-60 leukemia cells through inhibition of the PI3K-AKT signaling pathway
  346. Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells
  347. Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells
  348. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells
  349. Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax
  350. Wogonin induces Beclin-1/PI3K and reactive oxygen species-mediated autophagy in human pancreatic cancer cells
  351. Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells
  352. Wogonin induces cross‐regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells
  353. Wogonin induces differentiation and neurite outgrowth of neural precursor cells
  354. Wogonin induces eosinophil apoptosis and attenuates allergic airway inflammation
  355. Wogonin induces G1 phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21Cip1 in human cervical carcinoma HeLa cells
  356. Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells
  357. Wogonin induces retinal neuron-like differentiation of bone marrow stem cells by inhibiting Notch-1 signaling
  358. Wogonin induces the apoptosis of Lung cancer cells and its mechanisms research [J]
  359. Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up‐regulates phospholipid scramblase 1 gene expression
  360. Wogonin influences vascular permeability via Wnt/β‐catenin pathway
  361. Wogonin inhib its cytokineproduction and cell migration in microglial cells via NF-kB, not cAMP, dependent pathways
  362. Wogonin Inhibited Oral Squamous Cell Carcinoma Cells Proliferation and Invasion Through Modulation of the Wnt/β-Catenin Signaling Pathway
  363. Wogonin Inhibits Angiogenesis Via a c-Myc/Hif-1α–dependent Pathway in Multiple Myeloma
  364. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma
  365. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells
  366. Wogonin Inhibits Growth of Mantle Cell Lymphoma Cells through Nuclear Factor-κB Signaling Pathway
  367. Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-κB signaling pathway
  368. Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1
  369. Wogonin inhibits IGF-1-stimulated cell growth and estrogen receptor α expression in breast adenocarcinoma cell and angiogenesis of chick chorioallantoic membrane
  370. Wogonin inhibits IL-6-induced angiogenesis via down-regulation of VEGF and VEGFR-1, not VEGFR-2
  371. Wogonin inhibits inducible prostaglandin E2 production in macrophages
  372. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion
  373. Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4–MyD88–TAK1-mediated NF-κB and MAPK signaling …
  374. Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling
  375. Wogonin inhibits LPS-induced vascular permeability via suppressing MLCK/MLC pathway
  376. Wogonin inhibits microglial cell migration via suppression of nuclear factor-kappa B activity
  377. Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis
  378. Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells
  379. Wogonin inhibits osteoclast differentiation by inhibiting NFATc1 translocation into the nucleus
  380. Wogonin inhibits osteoclast formation induced by lipopolysaccharide
  381. Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR …
  382. Wogonin inhibits the proliferation of myelodysplastic syndrome cells through the induction of cell cycle arrest and apoptosis
  383. Wogonin Inhibits Transforming Growth Factor β1–induced Extracellular Matrix Production via the p38/activator Protein 1 Signaling Pathway in Nasal Polyp–derived …
  384. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein
  385. Wogonin inhibits tumor-derived regulatory molecules by suppressing STAT3 signaling to promote tumor immunity
  386. Wogonin inhibits Varicella-Zoster (shingles) virus replication via modulation of type I interferon signaling and adenosine monophosphate-activated protein kinase …
  387. Wogonin inhibits WEHI-3 leukemia cells in Blab/C mice In Vivo
  388. Wogonin mitigates intervertebral disc degeneration through the Nrf2/ARE and MAPK signaling pathways
  389. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro
  390. Wogonin modulates hydroperoxide-induced apoptosis via PI3K/Akt pathway in retinal pigment epithelium cells
  391. Wogonin overcomes cisplatin resistance of head and neck cancer by targeting antioxidant defense mechanisms
  392. Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species
  393. Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects
  394. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and …
  395. Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: Impact on PPAR-γ, inflammation, apoptosis and Wnt/β-catenin pathway
  396. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis
  397. Wogonin prevents glucocorticoid-induced thymocyte apoptosis without diminishing its anti-inflammatory action
  398. Wogonin prevents immunosuppressive action but not anti‐inflammatory effect induced by glucocorticoid
  399. Wogonin prevents lipopolysaccharide‐induced acute lung injury and inflammation in mice via peroxisome proliferator‐activated receptor gamma‐mediated …
  400. Wogonin prevents rat dorsal root ganglion neurons death via inhibiting tunicamycin-induced ER stress in vitro
  401. Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
  402. Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages
  403. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis
  404. Wogonin protects human retinal pigment epithelium cells from LPS-induced barrier dysfunction and inflammatory responses by regulating the TLR4/NF-κB …
  405. Wogonin protects rat dorsal root ganglion neurons against tunicamycin-induced ER stress through the PERK-eIF2α-ATF4 signaling pathway
  406. Wogonin reduces infarct size and improves ventricular function in chronic myocardial ischemia rats
  407. Wogonin regulated cell proliferation and apoptosis, and repressed miR-128 expression in human glioblastoma cell line U87
  408. Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
  409. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF‐1α and glycolysis, by inhibiting PI3K/Akt signaling pathway
  410. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling …
  411. Wogonin sensitizes resistant malignant cells to TNFα-and TRAIL-induced apoptosis
  412. Wogonin suppresses cellular proliferation and expression of monocyte chemoattractant protein 1 in Peyronie’s plaque‐derived cells
  413. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL‐6/STAT3 signaling pathway
  414. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro
  415. Wogonin suppresses melanoma cell B16-F10 invasion and migration by inhibiting Ras-medicated pathways
  416. Wogonin suppresses osteopontin expression in adipocytes by activating PPARα
  417. Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression
  418. Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes: suppressive effect of Wogonin on mite antigen …
  419. Wogonin suppresses the activity of matrix metalloproteinase-9 and inhibits migration and invasion in human hepatocellular carcinoma
  420. Wogonin suppresses the LPS‑enhanced invasiveness of MDA‑MB‑231 breast cancer cells by inhibiting the 5‑LO/BLT2 cascade
  421. Wogonin suppresses the production of breast cancer-derived osteolytic factors
  422. Wogonin suppresses TNF-α-induced MMP-9 expression by blocking the NF-κB activation via MAPK signaling pathways in human aortic smooth muscle cells
  423. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2
  424. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent …
  425. Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling …
  426. Wogonin, 5, 7‐dihydroxy‐8‐methoxyflavone as oestrogenic and anti‐implantational agent in the rat
  427. Wogonin, a bioactive flavonoid in herbal tea, inhibits inflammatory cyclooxygenase‐2 gene expression in human lung epithelial cancer cells
  428. Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways.
  429. Wogonin, a natural and biologically-active flavonoid, influences a murine WEHI-3 leukemia model in vivo through enhancing populations of T-and B-cells
  430. Wogonin, a natural flavonoid, intercalates with genomic DNA and exhibits protective effects in IL-1β stimulated osteoarthritis chondrocytes
  431. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in …
  432. Wogonin, a plant flavone from Scutellariae radix, attenuated ovalbumin-induced airway inflammation in mouse model of asthma via the suppression of IL-4/STAT6 …
  433. Wogonin, a plant flavone, potentiates etoposide‐induced apoptosis in cancer cells
  434. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells
  435. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by …
  436. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and …
Shopping Cart
Scroll to Top